Novel epitopic region of glucosyltransferase B from Streptococcus mutans

Tomonori Hoshino, Yoshio Kondo, Kan Saito, Yutaka Terao, Nobuo Okahashi, Shigetada Kawabata, Taku Fujiwara

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


In the development of a component vaccine against caries, the catalytic region (CAT) and glucan-binding domain (GBD) of glucosyltransferase B (GtfB) from Streptococcus mutans have been employed as target antigens. These regions were adopted as primary targets because they theoretically include epitopes associated with enzyme function. However, their antigenicities have not been fully evaluated. Although there are many reports about successful vaccination using these components, the principle has not yet been put to practical use. For these reasons, we came to doubt the effectiveness of the epitopes in vaccine production and reevaluated the antigenic region of GtfB by using in silico analyses combined with in vitro and in vivo experiments. The results suggested that the ca. 360-amino-acid variable region (VR) in the N terminus of GtfB is more reactive than CAT and GBD. This region is S. mutans and/or GtfB specific, nonconserved among other streptococcal Gtfs, and of unknown function. Immunization using an adenovirus vector-borne DNA vaccine confirmed that VR is an epitope that shows promise for the development of a caries vaccine.

Original languageEnglish
Pages (from-to)1552-1561
Number of pages10
JournalClinical and Vaccine Immunology
Issue number9
Publication statusPublished - 2011 Sept


Dive into the research topics of 'Novel epitopic region of glucosyltransferase B from Streptococcus mutans'. Together they form a unique fingerprint.

Cite this